HK Stock MarketDetailed Quotes

BIODLINK-B (01875)

Watchlist
  • 4.560
  • +0.020+0.44%
Market Closed May 15 16:06 CST
3.52BMarket Cap-31.67P/E (TTM)

BIODLINK-B (01875) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Turnover
-31.93%747.65M
-23.16%621.67M
-6.04%489.14M
13.33%252.2M
40.70%1.1B
49.27%809.02M
58.69%520.6M
67.79%222.54M
76.54%780.63M
77.25%541.98M
Operating income
-31.93%747.65M
-6.04%489.14M
40.70%1.1B
58.69%520.6M
76.54%780.63M
Cost of sales
-13.54%-358.67M
----
5.28%-136.1M
----
-52.87%-315.9M
----
-84.08%-143.7M
----
-188.76%-206.64M
----
Operating expenses
-13.54%-358.67M
5.28%-136.1M
-52.87%-315.9M
-84.08%-143.7M
-188.76%-206.64M
Gross profit
-50.29%388.98M
-6.33%353.04M
36.32%782.43M
50.76%376.91M
54.87%573.99M
Selling expenses
46.58%-324.09M
----
-0.35%-277.45M
----
-37.57%-606.71M
----
-40.08%-276.48M
----
-116.23%-441.02M
----
Administrative expenses
4.77%-77.49M
----
-8.16%-34.73M
----
-19.13%-81.38M
----
-3.22%-32.11M
----
-9.14%-68.31M
----
Research and development expenses
-8.02%-85.68M
----
22.65%-35.63M
----
23.66%-79.31M
----
7.82%-46.06M
----
31.28%-103.89M
----
Impairment and provision
-145.30%-3.63M
----
-94.61%509K
----
169.72%8.01M
----
1,868.96%9.45M
----
-1,823.12%-11.48M
----
-Other impairment is provision
-145.30%-3.63M
----
-94.61%509K
----
169.72%8.01M
----
1,868.96%9.45M
----
-1,823.12%-11.48M
----
Special items of operating profit
-38.45%11.21M
----
121.88%3.43M
----
3.18%18.22M
----
-88.46%1.55M
----
104.92%17.65M
----
Operating profit
-319.84%-90.69M
-72.40%9.18M
224.79%41.25M
328.17%33.26M
15.40%-33.06M
Financing income
-33.61%2.25M
----
-42.71%1.25M
----
13.75%3.38M
----
70.74%2.18M
----
31.30%2.97M
----
Financing cost
-20.67%-11.92M
----
-64.03%-6.37M
----
-90.92%-9.88M
----
-71.65%-3.88M
----
21.61%-5.18M
----
Share of profit from joint venture company
----
----
----
----
----
----
----
----
62.39%-2.5M
----
Earning before tax
-388.77%-100.37M
-87.13%4.06M
192.06%34.76M
308.15%31.56M
24.56%-37.76M
Tax
----
----
----
----
----
----
----
----
---1K
----
After-tax profit from continuing operations
-388.77%-100.37M
-87.13%4.06M
192.05%34.76M
308.13%31.56M
24.56%-37.76M
Earning after tax
-388.77%-100.37M
-109.52%-3.37M
-87.13%4.06M
-71.76%2.09M
192.05%34.76M
209.30%35.4M
308.13%31.56M
145.24%7.41M
24.56%-37.76M
22.28%-32.39M
Profit attributable to shareholders
-388.77%-100.37M
-109.52%-3.37M
-87.13%4.06M
-71.76%2.09M
192.05%34.76M
209.30%35.4M
308.13%31.56M
145.24%7.41M
24.36%-37.76M
20.10%-32.39M
Basic earnings per share
-380.00%-0.14
-75.00%0.01
200.00%0.05
300.00%0.04
37.50%-0.05
Diluted earnings per share
-380.00%-0.14
-75.00%0.01
200.00%0.05
300.00%0.04
37.50%-0.05
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
PwC
--
--
--
PwC
--
--
--
PwC
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Turnover -31.93%747.65M-23.16%621.67M-6.04%489.14M13.33%252.2M40.70%1.1B49.27%809.02M58.69%520.6M67.79%222.54M76.54%780.63M77.25%541.98M
Operating income -31.93%747.65M-6.04%489.14M40.70%1.1B58.69%520.6M76.54%780.63M
Cost of sales -13.54%-358.67M----5.28%-136.1M-----52.87%-315.9M-----84.08%-143.7M-----188.76%-206.64M----
Operating expenses -13.54%-358.67M5.28%-136.1M-52.87%-315.9M-84.08%-143.7M-188.76%-206.64M
Gross profit -50.29%388.98M-6.33%353.04M36.32%782.43M50.76%376.91M54.87%573.99M
Selling expenses 46.58%-324.09M-----0.35%-277.45M-----37.57%-606.71M-----40.08%-276.48M-----116.23%-441.02M----
Administrative expenses 4.77%-77.49M-----8.16%-34.73M-----19.13%-81.38M-----3.22%-32.11M-----9.14%-68.31M----
Research and development expenses -8.02%-85.68M----22.65%-35.63M----23.66%-79.31M----7.82%-46.06M----31.28%-103.89M----
Impairment and provision -145.30%-3.63M-----94.61%509K----169.72%8.01M----1,868.96%9.45M-----1,823.12%-11.48M----
-Other impairment is provision -145.30%-3.63M-----94.61%509K----169.72%8.01M----1,868.96%9.45M-----1,823.12%-11.48M----
Special items of operating profit -38.45%11.21M----121.88%3.43M----3.18%18.22M-----88.46%1.55M----104.92%17.65M----
Operating profit -319.84%-90.69M-72.40%9.18M224.79%41.25M328.17%33.26M15.40%-33.06M
Financing income -33.61%2.25M-----42.71%1.25M----13.75%3.38M----70.74%2.18M----31.30%2.97M----
Financing cost -20.67%-11.92M-----64.03%-6.37M-----90.92%-9.88M-----71.65%-3.88M----21.61%-5.18M----
Share of profit from joint venture company --------------------------------62.39%-2.5M----
Earning before tax -388.77%-100.37M-87.13%4.06M192.06%34.76M308.15%31.56M24.56%-37.76M
Tax -----------------------------------1K----
After-tax profit from continuing operations -388.77%-100.37M-87.13%4.06M192.05%34.76M308.13%31.56M24.56%-37.76M
Earning after tax -388.77%-100.37M-109.52%-3.37M-87.13%4.06M-71.76%2.09M192.05%34.76M209.30%35.4M308.13%31.56M145.24%7.41M24.56%-37.76M22.28%-32.39M
Profit attributable to shareholders -388.77%-100.37M-109.52%-3.37M-87.13%4.06M-71.76%2.09M192.05%34.76M209.30%35.4M308.13%31.56M145.24%7.41M24.36%-37.76M20.10%-32.39M
Basic earnings per share -380.00%-0.14-75.00%0.01200.00%0.05300.00%0.0437.50%-0.05
Diluted earnings per share -380.00%-0.14-75.00%0.01200.00%0.05300.00%0.0437.50%-0.05
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor PwC------PwC------PwC--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More